Health & Personal Care
HIGH
FDA DRUG
Immunocore Recalls KIMMTRAK Injection Over Subpotency — 7,572 Vials Affected
Immunocore recalled 7,572 vials of KIMMTRAK (tebentafusp-tebn) Injection due to subpotency concerns. This defect may compromise treatment efficacy for patients. Healthcare providers and patients should stop using the product immediately and consult for guidance.
IMMUNOCORE
Subpotent Drug